Deciphering a crucial dimeric interface governing Norrin dimerization and the pathogenesis of familial exudative vitreoretinopathy

Abstract Familial exudative vitreoretinopathy (FEVR) is a hereditary eye disease that could cause blindness. It has been established that Norrin forms dimers to activate β‐catenin signaling, yet the core interface for Norrin dimerization and the precise mechanism by which Norrin dimerization contributes to the pathogenesis of FEVR remain elusive. Here, we report an NDP variant, c.265T>C (p.Phe89Leu), that interrupted β‐catenin signaling by disrupting Norrin dimerization. Structural and functional analysis revealed that the Phe‐89 of one Norrin monomer interacts with Pro‐98, Ser‐101, Arg‐121, and Ile‐123 of another, forming two core symmetrical dimerization interfaces that are pivotal for the formation of a “hand‐by‐arm” dimer. Intriguingly, we proved that one of the two core symmetrical interfaces is sufficient for dimerization and activation of β‐catenin signaling, with a substantial contribution from the Phe‐89/Pro‐98 interaction. Further functional analysis revealed that the disruption of both dimeric interfaces eliminates potential binding sites for LRP5, which could be partially restored by over‐expression of TSPAN12. In conclusion, our findings unveil a core dimerization interface that regulates Norrin/LRP5 interaction, highlighting the essential role of Norrin dimerization on β‐catenin signaling and providing potential therapeutic avenues for the treatment of FEVR.